Creative Financial Designs Inc Editas Medicine, Inc. Transaction History

Creative Financial Designs Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	BUY	$18.5 - $34.34 $740 - $1,373	40 New	40 $1,000
Q1 2020 Apr 22, 2020	SELL	$14.88 - $32.78 $0 - $0	0 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$19.49 - $32.63 $1,948 - $3,263	-100 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$19.43 - $26.41 $1,943 - $2,641	-100 Reduced 50.0%	100 $2,000
Q3 2017 May 02, 2018	SELL	$15.81 - $24.01 $1,581 - $2,401	-100 Reduced 33.33%	200 $5,000
Q1 2017 May 02, 2018	BUY	N/A	300	300 $7,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.